BioNTech SE - ADR

NASDAQ:BNTX  
247.69
-2.64 (-1.06%)
Products, Business Deals, Strategic Combinations

Pfizer And Biontech To Provide 500 Mln Additional COVID-19 Vaccine Doses At Not-For-Profit Price

Published: 09/22/2021 10:16 GMT
BioNTech SE - ADR (BNTX) - Pfizer and Biontech Expand Collaboration With U.S. to Provide 500 Million Additional Covid-19 Vaccine Doses at Not-for-profit Price for Donation to Poorest Countries.
Effort Contributes to Companies' Pledge to Deliver Two Billion Covid-19 Vaccine Doses to Low- and Middle-income Countries by End of 2022.